Home4503 • TYO
Astellas Pharma Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 517.41B | 22.63% |
Operating expense | 343.99B | 5.14% |
Net income | -97.66B | -772.91% |
Net profit margin | -18.87 | -648.55% |
Earnings per share | — | — |
EBITDA | 126.06B | 91.43% |
Effective tax rate | 17.49% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 179.87B | -29.18% |
Total assets | 3.45T | 2.46% |
Total liabilities | 1.96T | 4.95% |
Total equity | 1.49T | — |
Shares outstanding | 1.79B | — |
Price to book | 1.76 | — |
Return on assets | 5.42% | — |
Return on capital | 7.69% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -97.66B | -772.91% |
Cash from operations | 16.03B | -68.83% |
Cash from investing | -30.72B | 23.79% |
Cash from financing | -104.30B | -19.85% |
Net change in cash | -113.13B | -41.38% |
Free cash flow | 13.83B | -53.18% |
Previous close
¥1,465.50
Day range
¥1,467.00 - ¥1,482.50
Year range
¥1,415.00 - ¥1,835.00
Market cap
2.67T JPY
Avg Volume
6.67M
P/E ratio
-
Dividend yield
4.87%
Primary exchange
TYO
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,754
